News

This horrific one-day chart sums up why biotech … – Business Insider

Google FinanceShares of Aerie Pharmaceuticals erased more than two-thirds of their value in a few minutes late on Thursday.The stock closed nearly 2% higher at $35.39 per share, giving the company a market value of $850 million. Then shortly after the end of trading, the company announced that Rhopressa, an experimental eye drop, failed a late-stage test.In after-hours trading, shares crashed by more […]

Aerie Pharma and why biotech investing is terrifying – Business Insider

Google FinanceShares of Aerie Pharmaceuticals erased more than two-thirds of their value in a few minutes late on Thursday.The stock closed nearly 2% higher at $35.39 per share, giving the company a market value of $850 million. Then shortly after the end of trading, the company announced that Rhopressa, an experimental eye drop, failed a late-stage test.In after-hours trading, shares crashed by more […]

Are Biotech Stocks in a Bubble? | David Chapman | Safehaven.com

Are Biotech Stocks in a Bubble?By: David Chapman | Thu, Apr 23, 2015SharePrintEmailCharts created using Omega TradeStation 2000i. Chart data supplied by Dial DataAre Biotech stocks in a bubble? This is a question that is being asked. According to an article by Bloomberg (Biotech Index in Nosebleed Territory – Up 500% In 4-years, Trades At 10X Revenues – Bloomberg Business, […]

3 Potent Biotech Stocks That Could Pop on Earnings | InvestorPlace

View All3 Potent Biotech Stocks That Could Pop on EarningsLike golf, investing in biotech stocks can be cruel game. As Michael A. Gayed explains, the pricing dynamic of individual biotech stocks will often follow the perceived successes — or failures — of drug trials and the multiple approval procedures enforced by regulatory agencies.Source: ©iStock.com/twilightproductionsThis Wild West mentality is primarily the […]

4 Biotech Stocks Poised to Jump 15% | InvestorPlace

View All4 Biotech Stocks Poised to Jump 15%It’s been something of a lackluster week for the broad market — but biotech has really shined.Source: FlickrWhile the S&P 500 was up just 1.3% as of Wednesday afternoon, biotechs as a group outperformed, gaining nearly 2.5%.7 Small-Cap Healthcare Stocks Set to Soar
This sector is famous for being a volatile one, so timing […]

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong …

Earnings season in the biotech sector started on a positive note with Amgen (AMGN – Analyst Report) reporting better-than-expected first quarter 2015 results. Meanwhile, The Medicines Co. (MDCO – Analyst Report) received some good news with an FDA advisory panel backing its antiplatelet agent. However, companies like Athersys (ATHX – Snapshot Report) and Ampio suffered setbacks on the pipeline front.Recap […]

4 Biotech and Pharma Stocks Projected to Rise 50 … – 24/7 Wall St.

Biotech has been one hot sector again in 2015. Two key biotech exchange traded funds are up 20% or so on average year-to-date. 247 Wall St. could not help but notice four analyst calls this past week in which upside of 50% to 100% was predicted for four biotech and specialty pharma stocks.Before just chasing these higher, investors should understand […]

Biotech Stocks Projected to Rise Up to 100% Include Intercept …

Biotech has been one hot sector again in 2015. Two key biotech exchange traded funds are up 20% or so on average year-to-date. 247 Wall St. could not help but notice four analyst calls this past week in which upside of 50% to 100% was predicted for four biotech and specialty pharma stocks.Before just chasing these higher, investors should understand […]

Biotech Stock Roundup: Favorable Briefing Documents for MDCO…

The Medicines Co. (MDCO – Analyst Report) was in the news for different reasons last week – while the company reported disappointing preliminary top-line results for the first quarter, later on the company received some good news with the FDA issuing positive briefing documents for Kengreal ahead of an advisory panel meeting. Other companies making it to the headlines over […]

The Biotech Stocks JMP Is Watching – Merck & Company, Inc …

Related MRKSunTrust’s Latest Comments On MerckMorgan Stanley’s Major Pharma Q1 PreviewMerck, NewLink Ebola Vaccine Enters Third Phase III Study – Analyst Blog(Zacks)Related Why Johnson & Johnson’s Strong Pharmaceutical Business Is A ConcernBenzinga’s Top UpgradesNew drug trial results positive(Investor’s Business Daily)In a report published Thursday, JMP Securities analysts expressed their views on Biotechnology stocks after the EASL abstracts were made available […]